Rep. Katie Porter Makes Pharma Exec Squirm Over Cancer Drug Price Hikes

Rep. Katie Porter (D-Calif.) and her trusty whiteboard are at it again. The congresswoman delivered one of her textbook takedowns during a House Committee on Oversight and Reform hearing Wednesday with current and former executives of three major drug companies. The committee is investigating the high cost of prescription drugs in the U.S. Porter began her grilling of Mark Alles, who served as CEO of Celgene until 2019, by asking about the…